Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Tegaserod: What's Old Is New Again
Gregory S. Sayuk et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia
Ifat Geron et al.
NATURE COMMUNICATIONS (2022)
Article The proteogenomic subtypes of acute leukemia
Ashok Kumar Jayavelu et al.
CANCER CELL (2022)
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
Valentina Gambacorta et al.
CANCER DISCOVERY (2022)
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
Clement Larrue et al.
NATURE COMMUNICATIONS (2021)
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy et al.
CANCER DISCOVERY (2021)
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
Liguo Wang et al.
NATURE CHEMICAL BIOLOGY (2021)
Advances in acute myeloid leukemia
Laura F. Newell et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Emerging agents and regimens for AML
Hongtao Liu
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Expression of Transient Receptor Potential Channel of Melastatin number 8 (TRPM8) in Non- Melanoma Skin Cancer: A Clinical and Immunohistochemical study
Aiat Shaban Hemida et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2021)
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia
Hardikkumar Jetani et al.
BLOOD (2021)
How I treat pediatric acute myeloid leukemia
Jeffrey E. Rubnitz et al.
BLOOD (2021)
Stepwise evolution of therapy resistance in AML
Philippe Gui et al.
CANCER CELL (2021)
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
L. C. Stetson et al.
LEUKEMIA (2021)
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
C. Glenn Begley et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-kappa B signaling axis
Guojin Wu et al.
NATURE CANCER (2021)
Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma
Hong Xie et al.
NATURE METABOLISM (2021)
New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Ramya Nair et al.
LEUKEMIA (2021)
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Bader Alanazi et al.
LEUKEMIA (2020)
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Gail J. Roboz et al.
BLOOD (2020)
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia
Basit Salik et al.
CANCER CELL (2020)
Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channel
Lizhen Xu et al.
NATURE COMMUNICATIONS (2020)
Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca2+ signals that are inhibited by oncogenic KRas
Stephen J. P. Pratt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structural basis of cooling agent and lipid sensing by the cold-activated TRPM8 channel
Ying Yin et al.
SCIENCE (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Irene Baccelli et al.
CANCER CELL (2019)
A fully human transgene switch to regulate therapeutic protein production by cooling sensation
Peng Bai et al.
NATURE MEDICINE (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V. Krivtsov et al.
CANCER CELL (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
Meidan Ying et al.
BLOOD (2018)
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
Allison L. Boyd et al.
NATURE CELL BIOLOGY (2017)
TRP channel mediated neuronal activation and ablation in freely behaving zebrafish
Shijia Chen et al.
NATURE METHODS (2016)
TRPM8: a potential target for cancer treatment
Zhaoguo Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
The TRPM2 ion channel is required for sensitivity to warmth
Chun-Hsiang Tan et al.
NATURE (2016)
VAMP7 regulates constitutive membrane incorporation of the cold-activated channel TRPM8
Debapriya Ghosh et al.
NATURE COMMUNICATIONS (2016)
TRP channel-associated factors are a novel protein family that regulates TRPM8 trafficking and activity
Dimitra Gkika et al.
JOURNAL OF CELL BIOLOGY (2015)
Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion
Nelson S. Yee
CANCERS (2015)
Direct inhibition of the cold-activated TRPM8 ion channel by Gαq
Xuming Zhang et al.
NATURE CELL BIOLOGY (2012)
Tegaserod - A new 5-HT4 agonist
BE Lacy et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)